Anthony E. Allegrezza
Millipore Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anthony E. Allegrezza.
Nature Biotechnology | 1992
Anthony J. DiLeo; Anthony E. Allegrezza; Stuart E. Builder
We describe a new class of membrane that has the capability of removing particles such as viruses from solution with resolution and reproducibility superior to that of conventional membranes. This composite membrane is composed of a pre-formed microporous membrane plus a thin asymmetric, finely porous retentive layer that is quite different from conventional ultrafilters. The protein sieving characteristics of this membrane are nearly equivalent to, but slightly less than, that of conventional 100,000 Dalton cut-off ultrafiltration membranes. This membrane uniquely shows particle retention characteristics that increase monotonically from 3 to 8 logs as a function of particle diameter in the range of 28 to 93 nm. The performance of this membrane in both a single stage and a two stage system show that 4 to 6 log overall removal of virus particles in the size range 30 to 70 nm is possible with simultaneous high recovery of product protein. Clearance factors exceeding 6 logs are possible with viruses larger than 78 nm. In addition, the performance of process systems containing this membrane is predictable in accordance with the general membrane properties and equilibrium mass balance models. This membrane system is fully validatable and can be used in conjunction with other validated operations in a downstream process to reliably achieve an overall reduction of 12 logs of known or putative virus particles.
Animal Cell TechnologyDevelopments, Processes and Products | 1992
Paul Sekhri; Anthony J. DiLeo; Anthony E. Allegrezza; Richard V. Levy
The increasing risk of viral contamination of therapeutic proteins derived from human or animal systems has led both producers of biologically based therapeutics and regulatory agencies to address issues of product safety that relate to to viral transmission. Millipore Corporation (Bedford, MA) has developed a unique and validatable system based on a new caliber of membrane filters successful in achieving reproducible high resolution removal of viruses from protein solutions. The structure and function of this novel membrane is discussed, as well as the experimental design and data employed in the development of a comprehensive mammalian virus validation package.
Archive | 1990
Anthony E. Allegrezza; Ellen C. Bellantoni
Archive | 1987
Anthony E. Allegrezza; Edmund T. Burke
Archive | 1990
Anthony J. DiLeo; Anthony E. Allegrezza; Edmund T. Burke
Archive | 1996
John Charkoudian; Anthony E. Allegrezza
Nature | 1991
Anthony J. DiLeo; Anthony E. Allegrezza
Membranes for the Life Sciences, Volume 1 | 2010
Anthony E. Allegrezza; Todd Ireland; Willem Kools; Michael W. Phillips; Bala Raghunath; Randy Wilkins; Alex Xenopoulos
Archive | 1997
Anthony E. Allegrezza; John Charkoudian; アンソニー・イー・アリグレザ・ジュニア; ジョン・チャークーダイアン
Archive | 1991
Anthony J. DiLeo; Anthony E. Allegrezza; Edmund T. Burke